1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Epiomic Epidemiology Series: Fabry Disease Forecast in 8 Major Markets 2015-2025

Epiomic Epidemiology Series: Fabry Disease Forecast in 8 Major Markets 2015-2025

  • October 2015
  • -
  • Black Swan Analysis Ltd132
  • -
  • 42 pages

Summary

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Fabry Disease in 8 Major Markets

Fabry disease is a lysosomal storage disorder, caused by a genetic defect in the alpha-galactosidase-A gene (?GLA-gene), localized on the long arm of the X-chromosome (Xq22). This gene is essential in the breakdown of fatty substances, otherwise substances like globotriaosylceramide, will accumulate in the arteries, narrowing them and reducing blood flow around the body. It is a multi-system disorder characterised by dermatologic angiokeratoma corporis diffusum and purpura haemorrhagica nodularis, but also affects ocular, auditory, cardiac, digestive and renal systems.

This report provides the current prevalent population for Fabry Disease across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Fabry disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Fabry disease include:

-Angiokeratoma
-Cornea verticillata (corneal whorling)
-Hearing loss
-Tinnitus
-Proteinurea
-Cardiac hypertrophy & arrhythmias
-Sweating dysfunction

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

-Able to quantify patient populations in global Fabry disease’s market to target the development of future products, pricing strategies and launch plans.
-Gain further insight into the prevalence of the subdivided types of Fabry disease and identify patient segments with high potential.
-Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
-Provide a level of understanding on the impact from specific co-morbid conditions on Fabry disease’s prevalent population.
-Identify sub-populations within Fabry Disease which require treatment.
-Gain an understanding of the specific markets that have the largest number of Fabry disease patients.

Table Of Contents

Epiomic Epidemiology Series: Fabry Disease Forecast in 8 Major Markets 2015-2025
Fabry Disease
Table of Contents
-List of Tables and Figures
-Introduction
-Cause of the Disease
-Risk Factors and Prevention
-Diagnosis of the Disease
-Variation by Geography/Ethnicity
-Disease Prognosis andClinical Course
-Key Co-morbid Conditions /Features Associated with the Disease
-Methodology for Quantification of Patient Numbers
-Top-Line Prevalence for Fabry Disease
-Hearing Loss in Fabry Disease
o Type of Hearing Loss
o Extent of Hearing Loss
-Associated Co-morbid Conditions of Fabry Disease
o Renal and Urinary Conditions
o Cardiovascular Affected Conditions
o Dermatological Conditions
o Ophthalmic Conditions
-Abbreviations and Acronyms used in the Report
-Other Black Swan Analysis Publications
-Black Swan Analysis Online Patient-Based Databases
-Patient-Based Offering
-Online Pricing Data and Platforms
-References
-Appendix


List of Tables
-WHO criteria for hearing impairment
-Prevalence of Angina, total (000s)
-Prevalence of Angina, males (000s)
-Prevalence of Angina, females (000s)
-Type of hearing loss in patients with Fabry disease, total (000s)
-Extent of hearing loss in patients with Fabry disease, total (000s)
-Prevalence of renal/urinary symptoms in patients with Fabry disease, total (000s)
-Renal/urinary incompetence in patients with Fabry disease, total (000s)
-Cardiac symptoms in patients with Fabry disease, total (000s)
-Heart conditions in patients with Fabry disease, total (000s)
-Dermatological symptoms in patients with Fabry disease, total (000s)
-Sweat disorders in patients with Fabry disease, total (000s)
-Capillary skin disorders in patients with Fabry disease, total (000s)
-Ocular symptoms in patients with Fabry disease, total (000s)
-Ocular conditions in patients with Fabry disease, total (000s)
-Abbreviations and Acronyms used in the report
-USA Prevalence of Fabry Disease by 5-yr age cohort, males (000s)
-USA Prevalence of Fabry Disease by 5-yr age cohort, females (000s)
-France Prevalence of Fabry Disease by 5-yr age cohort, males (000s)
-France Prevalence of Fabry Disease by 5-yr age cohort, females (000s)
-Germany Prevalence of Fabry Disease by 5-yr age cohort, males (000s)
-Germany Prevalence of Fabry Disease by 5-yr age cohort, females (000s)
-Italy Prevalence of Fabry Disease by 5-yr age cohort, males (000s)
-Italy Prevalence of Fabry Disease by 5-yr age cohort, females (000s)
-Spain Prevalence of Fabry Disease by 5-yr age cohort, males (000s)
-Spain Prevalence of Fabry Disease by 5-yr age cohort, females (000s)
-United Kingdom Prevalence of Fabry Disease by 5-yr age cohort, males (000s)
-United Kingdom Prevalence of Fabry Disease by 5-yr age cohort, females (000s)
-Brazil Prevalence of Fabry Disease by 5-yr age cohort, males (000s)
-Brazil Prevalence of Fabry Disease by 5-yr age cohort, females (000s)
-Japan Prevalence of Fabry Disease by 5-yr age cohort, males (000s)
-Japan Prevalence of Fabry Disease by 5-yr age cohort, females (000s)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global and Chinese Tinnitus rehabilitation instrument Industry, 2016 Market Research Report

Global and Chinese Tinnitus rehabilitation instrument Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Tinnitus rehabilitation instrument Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Tinnitus rehabilitation ...

Vagus Nerve Stimulators - Medical Devices Pipeline Assessment, 2016

Vagus Nerve Stimulators - Medical Devices Pipeline Assessment, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by Global Data

Vagus Nerve Stimulators - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Vagus Nerve Stimulators - Medical Devices Pipeline Assessment, 2016" provides ...

Otitis Media-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Otitis Media-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Otitis Media-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline ...

Tinnitus-pipeline Insights, 2016

November 2016 $ 1250

Otitis Media-api Insights, 2016

November 2016 $ 1250

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.